Meet the team

Board member
Founder & President
Founder & Chief Scientific Officer
Chief Executive Officer
Lead Technical Operations
Senior Lead Medical Affairs
Lead Strategic Marketing & External Opportunities
Communication Manager
Scientific Project Manager
Head of Scientific Board Pr of Oncology
Pr of Immunology
Pr. of Medical Oncology
Founder & President
Founder & Chief Scientific Officer
Chief Executive Officer
Lead Technical Operations
Senior Lead Medical Affairs
Lead Strategic Marketing & External Opportunities
Communication Manager
Scientific Project Manager
Head of Scientific Board Pr of Oncology
Pr of Immunology
Pr. of Medical Oncology

INCREASE IMMUNOGENICITY

Brenus’ manufacturing process overpasses the lack of immunogenicity & educates the immune system  with visible and multi-specific targets

REPRESENT HETEROGENEITY OF THE TARGETED INDICATION

Selection criteria of starting material (Allogeneic tumor cell lines)

  • Representative oncogenic drivers (TP53,BRAF,KRAS,…)
  • Cold & hot tumor cell lines
  • Resistances capacities (metabolic ; chemical & physical)

Increase antigenicity

Brenus’ manufacturing process overpasses the lack of antigenicity & educates the immune system  with broad & higher quality range of tumor antigens